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LETTERS TO THE EDITOR
Plasma Concentrations of
Bacterial Lipopolysaccharide:
A Marker of Infection or Inflammation?
The article by Wiedermann et al. (1) sheds more light on the
potential importance of elevated plasma concentrations of bacterial
lipopolysaccharide (LPS). This is, however, not the first published
report on elevated LPS concentrations in cardiovascular disease.
We proposed in 1997 that raised LPS plasma concentrations
(potentially as a consequence of intestinal translocation) might be
expected in patients with chronic heart failure (CHF) (2). Re-
cently, we have demonstrated that low grade but significant
endotoxemia is present in edematous patients with CHF, which
was lowered after diuretic treatment (3).
Wiedermann et al. (1) discuss the importance of chronic and
potentially repetitive infection as a cause for atherosclerosis. We
would like to ask the authors which clinical signs of acute or
chronic infection have or have not been documented in their study
group at the time of the initial investigation. Was the measure-
ment of body temperature included in the clinical evaluation
protocol? If there were patients with clinical signs of an ongoing
infection, did they have higher LPS plasma concentrations than
noninfected patients? Did the study’s principal results of the
relation between LPS and atherosclerosis remain the same after
exclusion of these patients? How often was the diagnosis of
infection based on biochemical measurements such as C-reactive
protein (CRP) alone? CRP is an acute-phase protein, and primar-
ily it is a sign of inflammation. Noninfectious processes such as
hypoxia have been shown to cause inflammatory cytokine activa-
tion (4), which in turn can raise CRP levels (5). The presence of
LPS in the bloodstream does not necessarily indicate the presence
of bacteria in the circulation or bacterial infection. An alternative
hypothesis to explain raised LPS levels in some patients in the
study (1) could be that bacterial translocation across the intestinal
wall occurs, potentially due to atherosclerotic processes in the
mesenteric vasculature, contributing to local tissue ischemia.
The report raises another very important point. To date, there is
no consensus on how to measure plasma LPS concentrations. In
contrast to the methodology applied by Wiedermann et al. (1), we
use LPS-free vacuum blood collection tubes (Endot Tube ET,
Chromogenix, Mo¨lndal, Sweden) (3). These tubes have been
developed specifically for the measurement of LPS plasma con-
centrations. After centrifugation, these tubes can be stored directly
in a freezer. This eliminates the aliquoting process at the time of
sampling in the clinic, which is thought to be the main source of
contamination. The processing of the samples can then be per-
formed under sterile laboratory conditions at the time of LPS
analysis. The use of standard tubes for the assessment of LPS
concentrations in blood may need validation.
We agree with Wiedermann et al. (1) and Carlquist (6) that the
pathophysiologic importance of bacterial LPS may potentially be
transferable to a much broader spectrum of clinical conditions
beyond sepsis. Although endotoxin antibodies have failed in septic
patients, they may be of value in patients with cardiovascular
diseases.
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REPLY
Chronic infections have been implicated in the etiology of atheroscle-
rosis, but this presumed association remains controversial (1). Pro-
spective data from the Bruneck study revealed an association between
atherosclerosis and endotoxemia, which was particularly evident in
smokers and patients with recurrent bacterial infections (2).
In an effort to identify patients with chronic infections or
conditions known to be associated with recurrent episodes of
exacerbation of infectious disease, we initiated an extensive screen-
ing process consisting of two consecutive phases (3). The first step
involved obtaining a detailed self-reported medical and medication
history, a thorough clinical examination, spirometric measure-
ments, laboratory tests including acute-phase reactants, serologic
markers of chronic infection and urinary analysis and a review of
Bruneck Hospital’s data bases and medical records provided by
general practitioners and dentists. The situation in Bruneck is
unique in that the majority of subjects are treated in the local
hospital, which offers the only facilities for radiography, computed
tomography, lung function testing and microbiologic tests in the
survey area. If data were inconclusive or incomplete, individuals
were, in a second step, referred for further optional examinations.
The diagnosis of common chronic infections was established
according to standard diagnostic criteria by an expert committee
including medical subspecialists, all of whom had no knowledge of
the results of the ultrasound evaluations. Blood samples were
drawn after an overnight fast and 12 h abstinence from smoking
(4). In patients with an acute infectious disease, samples were
drawn after an interval of at least six weeks from the time of the
outbreak of the disease. Thus, endotoxemia was not measured
during an acute infection or an episode of exacerbation of chronic
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